Notified bodies perform the re-certification of medical devices and of in vitro medical devices in a divergent manner. The practical application of requirements related to the relevant manufacturer documentation and to the extent of the related review results in a wide range of practices from targeted assessment of limited documentation to more comprehensive assessments that have comparable extent of those for the initial product verification. This results in huge differences in re-certification processes and relevant timelines and costs thereof.
Recital 20, Regulation (EU) 2026/977
In forcesince 4 May 2026